Atrium Health
Many patients with cancer do not have access to clinical trials based on where they live
Most counties in the United States do not have active cancer clinical trials, according to results of an ASCO analysis.
Proton therapy, IMRT comparably effective for low-, intermediate-risk prostate cancer
Photon and proton beam radiation therapies conferred similar outcomes for men with localized prostate cancer, according to results of a randomized phase 3 trial.
ACC celebrates 75 years of education and innovation, now looks to the future
ATLANTA — An independent board for cardiovascular medicine and more integration of health equity issues in education and training of cardiologists are among the priorities of the American College of Cardiology, its president said.
Revascularization rates higher with ‘CT first’ diagnosis of chest pain
Read-world data showed that more patients underwent subsequent revascularization after “CT first” evaluation for chest pain vs. other functional testing strategies, researchers reported.
Care of the athletic heart, from elite athletes to exercise enthusiasts
The Care of the Athletic Heart Conference at Heart House in Washington, D.C., catered to clinicians responsible for providing cardiovascular care to athletes, including those at the elite level and exercise enthusiasts.
FDA approves Ojjaara for myelofibrosis with anemia
The FDA approved momelotinib for treatment of patients with myelofibrosis and anemia regardless of prior myelofibrosis therapy.
Vorasidenib first ‘game changer’ in 20 years for patients with IDH-mutant grade 2 glioma
CHICAGO — Vorasidenib significantly improved PFS while delaying time to next intervention among certain patients with grade 2 isocitrate dehydrogenase 1- or 2-mutant glioma, according to data presented at ASCO Annual Meeting.
VIDEO: Lung cancer screening strategies, bite-sized learning, ‘a lot to be excited about’
NASHVILLE, Tenn. — In this Healio exclusive, Jaspal Singh, MD, FCCP, discusses trends and advancements coming out of the CHEST Annual Meeting.
ASH announces new executive committee members
Four individuals have been elected to American Society of Hematology’s executive committee.
Global STEMI treatment initiative yields care delivery benefits in low-resource countries
WASHINGTON — New, 2-year data from a global registry enrolling patients with STEMI in low- and middle-income countries showed continued improvement in trends for key clinical and system parameters, including mortality, researchers reported.